Neurodevelopmental outcomes at 2 years following ibuprofen treatment for patent ductus arteriosus in the preterm small for gestational age newborn: potential for neuroprotection (2020-2021)
Experts
Dr
Julie Wixey
Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Senior Research Fellow
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
